… in gliomas; these fusions are also retained in recurrent glioblastoma. … efficacy of erdafitinib in glioblastoma? de la Fuente highlighted … grade 4 F3T3 fusion–positive glioblastoma. This patient underwent biopsy … , WHO grade 4 glioblastoma that was MGMT promoter …

… specifically target these pathways in glioblastoma. The community eagerly anticipates follow … circNTRK2 regulates stemness properties of glioblastoma cells by activating STK31. … stem cell propertiesNSUN7 role in glioblastomaRNA biology in brain tumorsRNA …

… , MGMT-methylated, IDH wild-type glioblastoma. Lombardi explained that the trial …

… ? Currently patients with glioblastoma have a median survival … with diffuse intrinsic pontine glioma. What was the … therapy in patients with glioblastoma? This dose-escalation … with histologically confirmed recurrent glioblastoma, a Karnofsky performance score …

… Assessment in Pediatric Low-Grade Glioma radiological response criteria was 87% … included pilocytic astrocytoma (83%), diffuse glioma (6%), diffuse leptomeningeal glioneuronal tumor … recurrent/progressive low-grade glioma: update from the SJ901 ( …

… with IDH1- or IDH2-mutant glioma, the treatment combination of … in IDH1/2-mutated glioma? Although Voranigo is approved … with higher-grade, more aggressive gliomas. As such, de la … [IDH1/2-mutant] gliomas while controlling more rapidly proliferative …

… 39;t capable of curing glioblastomas without reinforcement from other therapeutic … , more effective treatments for glioblastoma and potentially other immune treatment … spherical nucleic acids reprogram the glioblastoma immune microenvironment and promote …

… infusion in patients with recurrent glioblastoma, meeting the primary safety objective … patients with diffuse intrinsic pontine glioma.2 What was the design … age with histologically confirmed recurrent glioblastoma, a Karnofsky performance score of …

… slow-growing IDH-mutant gliomas, researchers have reported — … patients with [IDH]-mutated glioma were managed with observation, … with WHO grade 3 glioma also underwent observation.” Researchers … patterns in IDH-mutated glioma: Implications for targeted therapy …

… with isocitrate dehydrogenase–mutated glioma, including both newly diagnosed … 50% were diagnosed with glioma one to five years … they had a confirmed glioma diagnosis, underwent surgery before … either surgery only or glioma diagnosis only revealed results …